Mise en page 1

Transcription

Mise en page 1

JDP 2014
Journées Dermatologiques de Paris
0 9 -1 3 DEC EMB ER 2014
O RG A NI SI NG C OM M IT T E E :
C . BE DA NE - N . D U PI N - M . T. LE CCI A
C ONGR ES S C OO RD I N AT I O N :
S . FOJ U TO W S KI
SFD SEC R ETAR IAT:
F. DU MO N T
Te l. : + 33 0 1 4 3 2 7 0 1 6 7
F ax : +3 3 0 1 4 3 2 7 0 1 8 6
Preliminary
programme
English
10-14 décembre 2014
Porte Maillot
www.jdp2014.com
09-13 December 2014
Journées Dermatologues de Paris
Palais des Congrès
Message from the President of the French Society of Dermatology (SFD)
Société Française de Dermatologie
25 rue La Boétie – 75008 PARIS
[email protected]
Dear Colleagues, Dear Friends,
The Journées Dermatologiques de Paris will be held at the Palais des Congrès, Paris,
from: 9 to 13 December 2014.
The scientific programme has once again been frame-worked to meet the expectations of the entire community, taking
into consideration its different centres of interests, concerns and places of practice.
Topics, experts and session formats have been selected to give insights in many fields of dermatology and to offer
excellence in education.
The programme will feature altogether 2 plenary sessions, 9 workshops, 85 continuing education sessions (FMC in
French), 19 forums and over 500 oral and poster presentations; not to be missed will be also the traditional What’s
new session on Saturday morning.
I am very pleased to announce that this year the number of sessions providing simultaneous interpretation (in English)
has been considerably increased: 20 FMC (CME), all plenary sessions, What’s new, Hot topics and latest news in
Dermatology.
This reflects the JDP goal and will to go beyond boundaries and reach out to experiences and views from more
environments.
During the JDP, you will have the opportunity to also view the scientific posters (available both on poster boards and
electronic format) in dedicated areas and on the “Maison de la Dermatologie” booth.
I encourage you to visit the congress web site to discover the full detailed programme and the array of educational and
networking activities proposed by the JDP as well as the SFD missions and initiatives:
http://www.jdp2014.com
On behalf of the French community, I invite you to join us in December to share with us a rich learning experience and
establish valuable connections which, I am confident, will continue and flourish after the congress.
Yours sincerely
Professor Olivier Chosidow
President of SFD
2
www.jdp2014.com
Porte Maillot
Contents
Schedule at a glance
Sessions simultaneously translated
General information and conditions
Exhibition
Social events
Page
Page
Page
Page
Page
4
6
20
24
24
Organising Committee
Christophe BEDANE (Limoges)
Nicolas DUPIN (Paris)
Marie-Thérèse LECCIA (Grenoble)
Scientific Programme Committee
Fabienne LEONARD (Reims)
Laurence OLLIVAUD (Charenton-le-Pont)
Jean-François STALDER (Nantes)
Pierre-Emmanuel STOEBNER (Nîmes)
Philippe CELERIER President (La Rochelle)
Valérie DOFFOEL-HANTZ (Limoges)
Anne DOMPMARTIN (Caen)
Nathalie GRAL (Grenoble)
François HABIB (Avignon)
Abstracts Reviewing Committee
Frédéric AUGEY (Pierre Bénite)
Frédéric CAUX Président (Bobigny)
Patrick COMBEMALE (Lyon)
Alain DUPUY (Rennes)
Caroline GAUDY MARQUESTE (Marseille)
Smaïl HADJ-RABIA (Paris)
Thomas JOUARY (Bordeaux)
Laurent MORTIER (Lille)
Philippe MUSETTE (Rouen)
Saskia ORO (Créteil)
Antoine PETIT (Paris)
Patricia SENET (Paris)
Key date
07 November 2014
Advance registration deadline
3
Palais des Congrès
English
09-13 December 2014
4
14h00 or 14h15 15h30 or 15h45
18h00 - 19h00
Satellite symposium
Satellite symposium
FMC (CME) 79 :
Cutaneous adverse effects of targeted
therapies in oncology
FMC (CME) 85 :
Lymphedema in children
FMC (CME) 74 - 75 - 76 - 77 - 78 - 80 - 81 82 - 83 - 84
Forum 19
Posters presentation discussion Session 2
FMC (CME) 68 :
Pigmentation disorders
FMC (CME) 69 :
Toxidermia: News on causality
assessment, new alerts
FMC (CME) 64 - 65 - 66 - 67 - 70 - 71 - 72 - 73
Forum 15 (continued) - 18
Posters presentation discussion Session 1
Schedule at a glance
FMC (CME) 49 :
2014 News in Psoriasis
FMC (CME) 54 :
Skin and GI tract
FMC (CME) 47 - 48 - 50 - 51 - 52 - 53 - 55 - 56
Forum 13 - 14
Oral communications
FMC (CME) 43 :
Various forms of scabies
FMC (CME) 46 :
Managing bacterial skin
infections: The keys to using
antibiotics wisely
FMC (CME) 38 - 39 - 40 - 41 - 42 - 44 - 45
Forum 11 - 12
EF1
Oral communications
Workshop 9 (continued)
FMC (CME) 18 : Inflammatory
dermatoses or autoinflammatory diseases: Diagnosing neutrophil infiltration
FMC (CME) 21 : Managing vitiligo
combined with one or more autoimmune
diseases
FMC (CME) 16 - 17 - 18 - 19 - 20 - 22 - 23
Forum 5 - 6
Special session (to be continued)
Oral communications
Satellite symposium
Plenary Sessions :
- State-of-the-art Gene Therapy in 2014 Pierre Hainaut
- Metabolism, Ageing and Cancer
Marina Cavazzana
Forum 15 (continued)
16h15 - 17h45 or
18h00
SATURDAY 13 DECEMBER
09-13 December 2014
FMC (CME) 25 :
Tanning addiction and tanning beds
FMC (CME) 28 :
How to manage nail tumors in adults?
FMC (CME) 17 (continued) - 24 - 26 - 27 - 29
Forum 7 - 8
Special session (continued)
Oral communications
Satellite symposium
Plenary Session :
End-of-life Ethics Jean-Claude Ameisen
Satellite symposium
FMC (CME) 10 :
Optimizing safety and efficacy of
conventional systemic treatments and
biotherapies for psoriasis
FMC (CME) 12 :
Controversies about
sunscreens: Are sunscreens
and antioxidant supplements risky?
What should we tell our patients?
FMC (CME) 9 - 11 - 13 - 14 - 15
Forum 3 - 4
Special session (to be continued)
Oral communications
Latest News in Dermatology 1
FRIDAY 12 DECEMBER
What's New ?
FMC (CME) 30 : Optimizing diagnosis
FMC (CME) 59 :
and management of aggressive or advanNews in bradykinin-mediated
What’s new in clinical dermatology ?
ced basal cell carcinoma
angioedema
FMC (CME) 34 :
What’s new in instrumental
FMC (CME) 63 :
In what ways do new treatments for
dermatology ?
Condyloma and intraepithelial neoplasia:
metastatic melanoma alter patient
What’s new in internal medicine ?
Is a work-up necessary? If so, which one?
management?
FMC (CME) 57 - 58 - 60 - 61 - 62
What’s new in pediatric dermatology ?
FMC (CME) 31 - 32 - 33 - 35 - 36 - 37
Forum 15 - 16 - 17
What’s new in cancerology ?
Forum 9 - 10
Latest News in Dermatology 2
Oral communications
What’s new in dermatological
Oral communications
Hot Topics
treatment ?
THURSDAY 11 DECEMBER
12h30 - 13h30
Workshop 1
(group C-D)
Workshop 2
(group A-B)
Workshops 3 et 4
(to be continued)
Workshop 6
Workshop 1
(group A-B)
Workshops 3, 4, 5,
7, 8
Workshop 9
FMC (CME) 1 :
Therapeutic news in infectious
skin diseases
FMC (CME) 3 :
Recurrent mouth ulcers
FMC (CME) 2 - 4 - 5 - 7 - 8
Forum 1 - 2
Special session
Oral communications
WEDNESDAY 10 DECEMBER
Porte Maillot
11h00 - 12h30 or
13h00
8h30 or 9h0010h30
TUESDAY 09 DECEMBER
English
www.jdp2014.com
Palais des Congrès
Simultaneous interpretation into English
English
Programme
Translated sessions
Full programme (French version) is available on the congress web site : www.jdp2014.com
The following pages describe those sessions of the programme in which simultaneously interpretation is provided into English :
- Plenary sessions
- Hot topics and latest news in dermatology sessions
- FMC (CME) N°1 – 3 – 10 – 12 – 18 – 21 – 25 – 28 – 30 – 34 – 43 – 46 – 49 – 54 – 59 – 63 – 68 – 69 – 79 – 85
- What’s New ?
English
Porte Maillot
www.jdp2014.com
09-13 December 2014
Palais des Congrès
Plenary sessions
▼ Thursday 11 December
Amphithéâtre Bleu (level 2) 11h00 – 12h00
11h00 - 12h00 End-of-life Ethics
Prof. Jean-Claude Armeisen
▼ Friday 12 December
Amphithéâtre Bleu (level 2) 11h00 – 12h30
11h00-11h30
State-of-the-art Gene Therapy in 2014
Prof. Marina Cavazzana
11h30-12h30
P.53: Metabolism, Ageing and Cancer
Prof. Pierre Hainaut
6
09-13 December 2014
Palais des Congrès
OTHER SESSIONS
00 to 12h30
Wednesday 10 December 2014 from 11h
to 10h30
Friday 12 December 2014 from 09h00
sessions during which exper ts in a specific topic
« Latest news in DERMATOLOGY » are 1H30
een
coordination of a moderator; discussions betw
will give a 15-minute presentation under the
ask
to
y
rtunit
oppo
the
have
d and the audience will
the attendees and speakers will be encourage
which
s
topic
hot
are
ons
es covered in these sessi
questions in the room (5 min per topic). Them
are worth being discussed during our congress.
which
and
ice
pract
influence our daily dermatology
HOT TOPICS
Thursday 11 December 2014 from
09h00 to 10h30
The « HOT TOPICS » session will also
cover important issues of our professio
n but topics and
speakers will be selected by the
congress attendees. Topics and spea
kers
will be proposed
by the 3 governing bodies involved
in the organisation of JDP (the orga
nisin
g committee,
representatives from the SFD Board,
representatives from the editorial com
mitte
e
of
the “Annales
de dermatologie”). Congress attendees
will be invited to choose 6 topics amo
ng
the
18
proposed
by the 3 bodies (6 per body); they
will be able to choose their preferre
d
topic
s
in
a
dedi
cated
section of the online registration form
. Top selected themes will make up the
sess
ion
prog
ram
me.
Interaction and discussions will also
be an important part of this session.
7
English
Porte Maillot
www.jdp2014.com
English
Wednesday, December 10
09-13 December 2014
Porte Maillot
Palais des Congrès
▼ 09h00 – 10h30
FMC (CME) 1
Therapeutic news in infectious skin diseases
E. CAUMES, V. DESCAMPS, P. DEL GIUDICE
Moderator: F. CARSUZAA
General presentation:
Anti-infective therapies must address a
three-fold challenge:
- Adapt to germ evolution and plasticity,
be they conventional or emerging germs,
and to the unique features of susceptible
individuals (age, immune status,
comorbidities).
- Reduce and prevent resistance,
particularly to antibiotics (2011-2016
National Alert Plan) and antiparasitics.
- Be part of a cost-control and sustainable
development approach.
Objectives:
- Advance current anti-infective
therapeutic strategies by dermatologists
against common community-acquired
infections.
- Review future anti-infective therapies.
Learning outcomes:
- Know the main anti-infective agents
available and their modes of
prescription: dosage, duration of
treatment, adverse effects.
- Know their indications.
▼ 09h00 – 10h30
FMC (CME) 3
Recurrent mouth ulcers
C. FRANCES, M. PIRAM, M. SAMIMI
Recurrent aphthous stomatitis is a
multifactorial disease common in the
general population. Suitable management
entails recognizing the various clinical
forms and differentiating them from other
types of recurring oral lesions. In order to
provide the most appropriate treatment
plan, one must also be able to identify or
rule out the inflammatory, dysimmune,
infectious or deficiency-related diseases
that may emerge or combine with
recurrent aphthous stomatitis.
8
Objectives:
1/ Review management of idiopathic
mouth ulcers.
2/ Know which diseases are evoked by
recurrent aphthous stomatitis in
children and adults, and discuss the
clinical approach, choice of additional
tests and treatment plan.
3/ Recognize differential diagnoses for
mouth ulcers, based on clinical cases.
Learning outcomes:
After this session, the dermatologist
should be able to identify the clinical
elements suggestive of a disease
associated with recurring mouth ulcers,
request appropriate additional tests and
know the main treatment strategies.
Porte Maillot
Palais des Congrès
▼ 11h00 – 12h30
FMC (CME) 10
Optimizing safety and efficacy of conventional systemic treatments and biotherapies
for psoriasis
F. AUBIN, H. BACHELEZ, N. BENETON - Coordinator: M. VIGUIER
On behalf of «Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie»
The therapeutic armamentarium for
treating psoriasis has expanded
considerably in recent years with the
emergence of biotherapeutics, and will
continue to grow in the years to come.
However, conventional treatments for
psoriasis remain highly instrumental in
managing this chronic disease. The use of
biotherapeutics is governed by wellestablished rules of prescription, one
prerequisite being failure to respond to
two prior systemic treatments such as
methotrexate, cyclosporine or
phototherapy. In addition, gradual
tachyphylaxis to biotherapeutics is
frequently observed. For the benefit of the
patient, it is therefore essential to make
the most of each therapeutic strategy,
should systemic treatment of psoriasis
become necessary.
Objectives:
After reviewing the goals of treatment for
psoriasis, we will look at each of the
following treatments. Depending on the
clinical form, we will determine when to
assess efficacy and how to increase
efficacy while maintaining optimum safety
through increased dosage, alternate
route of administration, related
measures, combination therapy,
increased frequency of administration,
rotational strategies, and so forth.
- Acitretin (F. Aubin)
- Phototherapy (F. Aubin)
- Methotrexate (N. Bénéton)
- Cyclosporine (N. Bénéton)
- Anti-TNF, anti IL-12/IL-23 agents (H.
Bachelez)
Learning outcomes:
After this CME course, participants will
know how to prescribe the most
appropriate systemic treatments for
psoriasis, in order to optimize the efficacy
/ safety balance in real life conditions.
▼ 11h00 – 12h30
FMC (CME) 12
Controversies about sunscreens: Are sunscreens and antioxidant supplements risky?
What should we tell our patients?
J.C.BEANI, C. BEDANE, M.T. LECCIA
What resources are currently available
for appropriate sun protection of adults
and children? Are sunscreens effective
and what are the limits to their use?
Should oral antioxidants be
recommended? Are there other sun
protection strategies?
Objectives:
- Respond to growing patient concerns
about the risks of sunlight exposure, the
real or imagined risks pertaining to
sunscreens, and what we can expect
from existing sun protection methods
based on available scientific evidence.
- Recommend and select sun protection
methods suitable for specific individuals
(age, phototype, desired protection level)
and sunlight conditions.
Each theoretical talk will be illustrated by
hands-on clinical cases.
9
Learning outcomes:
- Know the side effects, expected benefits
and limitations of various sun protection
methods in terms of acute and chronic
sun damage.
- Clearly differentiate between sun
protection for children or teenagers, and
for adults.
- Provide individual advice to patients
based on their personal characteristics,
environment and sun-protection
expectations.
English
09-13 December 2014
English
09-13 December 2014
Porte Maillot
Palais des Congrès
▼ 14h15 – 15h45
FMC (CME) 18
Inflammatory dermatoses or autoinflammatory diseases: Diagnosing neutrophil
infiltration
S. ORO, N. ORTONNE, E. SBIDIAN
Moderator: H. BACHELEZ
Many clinically polymorphic dermatoses
are characterized by a neutrophil-rich skin
infiltrate. The cutaneous lesions may be
the result of neutrophilic dermatosis,
whether standalone or indicative of an
underlying inflammatory or hematological
disorder. The lesions may also be part of
a complex systemic involvement such as
the recently isolated monogenic autoinflammatory syndromes. Therefore,
diagnosing a neutrophil infiltration of the
skin requires the cross-referencing of
clinical, histological, biological and,
possibly, genetic testing data. The clinical
and histological characterization of
elementary lesions, be they associated
with extra-cutaneous manifestations or
not, helps to achieve a diagnosis or, at
least, narrow down possibilities.
Objectives:
- Present various forms of neutrophilic
dermatosis through hands-on, interactive
clinical cases.
- Guide dermatologists in their discussions
and bring to their attention a number of
proposed pathological and biological
investigations to advance diagnosis.
Reiterate the important role played by
these examinations and diagnostic
algorithms.
- Review auto-inflammatory syndromes.
Learning outcomes:
- Advancing the diagnosis of neutrophilic
dermatosis.
- Interpreting pathology data.
.
▼ 14h15 – 15h45
FMC (CME) 21
Managing vitiligo combined with one or more autoimmune diseases
L. BENZEKRI, K. EZZEDINE, Y. GAUTHIER
The combination of vitiligo with certain
autoimmune / auto-inflammatory
diseases such as varied dermatoses and
systemic, most often polyendocrine,
disorders, has been extensively
demonstrated genetically and
epidemiologically.
10
Objectives:
The goal of this CME course is to identify
which autoimmune disorders are likely to
be significantly associated with vitiligo and
to assess the impact of such associations
on choice of tests, prognosis and
proposed treatments.
Learning outcomes:
Having explored one or more associated
autoimmune diseases in the course of
this session, the participants should know
the impact of such associations, their
shared pathogenic connections and their
nosological frameworks. Dermatologists
should also be able to order laboratory
work-ups and propose a treatment for
vitiligo, considering both preferred
indications and contraindications.
Porte Maillot
Palais des Congrès
▼ 16h15 – 17h45
FMC (CME) 25
Tanning addiction and tanning beds
M. BONIOL, Ay. PETIT, E. MAHE
On behalf of «Société Française de Photodermatologie (SFPD)»
With the rising incidence of skin cancer,
the use of tanning beds has been
incriminated as a skin carcinogenic factor.
According to data from Europe and
America, indoor tanning is increasingly
popular. France is catching up in the
tanning salon « market », with figures
showing that more than 10% of French
people used tanning beds in 2010.
Meanwhile, regulations are changing
nationally and internationally.
Objectives:
The goal of this CME course is to provide
a 2014 update on tanning beds,
risk/benefit, epidemiology in France and
consumer profiles. We will look at:
- Proven health risks and possible benefits
of using tanning beds,
- Epidemiology of tanning-bed users in
France, with cross-country comparisons,
- Profiles of tanning-bed addicts,
- Update on regulatory changes.
Learning outcomes:
By the end of the session, participants will
know the risk / benefit ratio of using
tanning beds. The course will provide
updates on regulations and epidemiology,
allowing for a better understanding of
indoor tanning consumer profiles.
▼ 16h15 – 17h45
FMC (CME) 28
How to manage nail tumors in adults?
V. BLATIERE, O. COGREL, E. DUHARD
Under the hospices of «Groupe Chirurgical de la Société Française de Dermatologie»
Nail tumors are common. Though clinical
signs may be deceiving, nail tumors are
most often diagnosed clinically and
managed surgically. This richly illustrated
session will review the main tumors
affecting the nail apparatus in frequent
clinical situations. Simple but key surgical
management techniques will be
addressed in detail.
11
Objectives:
Review the various structures of the nail
apparatus where tumors may originate.
Know the main semiological aspects of
nail tumors and identify the features
indicating a benign or malignant origin.
Learn management strategies and key
surgical techniques.
The main goal is to capitalize on
photographic / imaging data from
experienced practitioners to help
participants detect serious tumors
requiring prompt management.
Learning outcomes:
After this course, participants will find it
easier to distinguish malignant from
benign tumors and will be familiar with
existing management strategies for
tumors of the nail apparatus.
English
09-13 December 2014
English
Thursday, December 11
09-13 December 2014
Porte Maillot
Palais des Congrès
▼ 09h00 – 10h30
FMC (CME) 30
Optimizing diagnosis and management of aggressive or advanced basal cell
carcinoma
M. BEYLOT-BARRY, J.M. AMICI, B. CRIBIER
Basal cell carcinoma (BCC) is the most
common type of skin cancer.
Management of most BCCs is simple and
well established, with surgery as the first
line of treatment. However, aggressive or
advanced BCC may be difficult to
differentiate from adnexal carcinoma.
Another issue is the limits of surgery,
where special expertise is required,
warranting a discussion of additional or
alternative treatments.
Objectives:
We start by defining what aggressive or
advanced BCC means. Surgical options
are then illustrated, on the basis of tumor
type, location and progression, as well as
surgical expertise. We will also discuss
the role of alternative or combined
treatments such as radiation therapy and
Hedgehog signaling pathway inhibitors.
The differential diagnosis for aggressive
BCC (adnexal carcinoma) will be
discussed, along with the impact of
diagnosis on patient management.
Learning outcomes:
Acquiring tools for critical analysis plus
understanding current advances, to
improve diagnosis and management of
aggressive or advanced BCC.
▼ 09h00 – 10h30
FMC (CME) 34
In what ways do new treatments for metastatic melanoma alter patient
management?
B. DRENO, M.T. LECCIA, B. GUILLOT
Treatment of metastatic melanoma has
changed considerably in recent years.
Ipilimumab, an anti-CTLA4 antibody, was
granted marketing authorization in France
as a second-line treatment and just
received marketing authorization in the EU
as a first-line treatment. BRAF inhibitors
vemurafenib and dabrafenib are now
available as targeted therapies.
These treatments are undergoing trials as
adjunct therapies. New regimens with
other targeted therapies (MEK or cKIT
inhibitors) or other immunotherapies (antiPD1 antibodies) are in the pipeline. The
advent of targeted therapies brings about
new management techniques for tumor
samples (tissue banks) and mutation
detection kits (genetics platforms).
New decision trees for treatment are also
12
being established for each stage of the
disease. New arrangements for patient
follow-up are necessary after melanoma
was recently branded a « chronic
disease ». This means strengthening ties
between private and hospital
dermatologists, particularly via community
/ hospital networks.
Lastly, new side effects must be
managed, requiring specific therapeutic
education to empower patients, and
proper collaboration between patients and
physicians. As treatment is often available
on an outpatient basis, management of
side effects must be provided at the
doctor’s practice, in line with patient
expectations.
Objectives:
Interactive clinical cases are presented
for discussion of treatment choices in
adjunct and curative settings. Decision
trees will be used in these clinical cases
for treatment of various types of
metastatic melanoma. Other topics for
discussion include managing the side
effects of new treatments and the
importance of therapeutic education.
Learning outcomes:
Familiarity with new treatments for
melanoma; discussing new decision trees;
managing tumor samples for targetedtherapy purposes; knowing the side
effects of new treatments and how to
manage them; the resulting need for
therapeutic education.
Interactive keypad session
Porte Maillot
Palais des Congrès
▼ 14h15 – 15h45
FMC (CME) 43
Various forms of scabies
F. BORALEVI, J.L. PERROT, C. BUZENET
Moderator: O. CHOSIDOW
Scabies is a fairly routine reason for
consulting a dermatologist. The clinical
presentation may be deceiving and there
are many therapeutic difficulties – for
example, with infantile scabies, profuse
and community-acquired forms.
Objectives:
Dermatologists must remain experts in
human scabies. Based on clinical cases,
guidelines and comments on research,
the presenters propose methods for
perfecting diagnosis using clinical practice
and morphological examination, plus
treatment options in common, everyday
practice in mainland France. The session
will also focus on hyperkeratotic and
infantile forms, as well as scabies in
developing countries.
Learning outcomes:
Knowing the sometimes misleading clinical
presentations indicative of human
scabies; shoring up a clinical diagnosis
using suitable diagnostic methods;
establishing a treatment plan and
providing useful guidance to patients and
their loved ones.
▼ 14h15 – 15h45
FMC (CME) 46
Managing bacterial skin infections: The keys to using antibiotics wisely
B. SASSOLAS, S. ANSART, D. TANDE
There are frequent, new developments in
microbial ecology - such as the
emergence of MRSA in cities - as well as
new investigative tools in bacteriology.
Management of bacterial skin infections
must adapt to those changes, both for
diagnosis and treatment.
13
Objectives:
Train and assist clinical dermatologists to
use both clinical and bacteriological data
in their practice. Based on clinical
observations, this CME session seeks to
provide dermatologists with an update on
existing diagnostic tools. These tools will
provide the knowledge base to fuel
treatment-planning discussions for simple
or complex bacterial skin infections.
Differential diagnosis is also addressed.
Learning outcomes:
This course will give participants an
update on the contribution of laboratory
work-ups to management of bacterial skin
infections. It also provides guidance on
managing fever presumably caused by
infection. The overarching goal is to
promote wiser use of antibiotics.
English
09-13 December 2014
English
09-13 December 2014
Palais des Congrès
Porte Maillot
▼ 16h15 – 17h45
FMC (CME) 49
2014 News in Psoriasis
M. BEYLOT-BARRY, D. JULLIEN, M.A. RICHARD
On behalf of «Recherche sur le Psoriasis de la Société Française de Dermatologie»
The abundance of literature on psoriasis
(over 3,000 PUBMED references in
2013) shows the extent of the medical
and scientific community’s interest in the
disease and its epidemiological,
physiopathological, clinical, therapeutic
and even societal ramifications.
Objectives:
In this CME session, three authors active
in the field of psoriasis will present
participants with a selection of papers.
They will review and comment on major
2014 publications on psoriasis, targeting
those useful to the daily practice of
dermatology. Priority topics include the
latest developments in physiopathology
and individualized psoriasis phenotypes,
plus therapeutic advances in conventional
systemic treatments, small molecules,
IL17 inhibitors, and JAK inhibitors. Other
topics include the use of clinical and
epidemiological data to provide patients a
multidisciplinary approach to daily
management of psoriasis.
Learning outcomes:
Improve routine, hands-on management
of psoriasis by both private and hospital
dermatologists.
▼ 16h15 – 17h45
FMC (CME) 54
Skin and GI tract
F. AUBIN, E. DELAPORTE, V. DESCAMPS
There are many interactions between
Dermatology and Hepato-Gastroenterology
such as liver diseases, Biermer’s anemia,
celiac disease, dermatitis herpetiformis,
psoriasis, Verneuil’s disease, chronic
intestinal inflammatory diseases,
pancreatopathies, and so forth.
Dermatologists may sometimes suspect a
GI involvement and, conversely, may be
asked to manage the cutaneous
manifestations of GI disorders.
14
Objectives:
This CME session seeks to address the
two clinical questions below:
- When does a dermatologist need a
gastroenterologist?
- When does a gastroenterologist need a
dermatologist?
Interactive clinical cases will serve as
examples of diagnostic and therapeutic
management.
Learning outcomes:
By the end of the session, participants will
know which skin manifestations suggest
GI disease and which additional tests are
necessary to confirm the diagnosis. As
dermatologists, they will know how to
respond to requests from their HepatoGastroenterology colleagues for managing
the cutaneous manifestations of GI
disorders.
FM
Friday, December 12
Porte Maillot
Palais des Congrès
▼ 09h00 – 10h30
FMC (CME) 59
News in bradykinin-mediated angioedema
H. MAILLARD, F. PELLETIER, L. MARTIN
Bradykinin-mediated angioedemas (BKmediated AE) are no longer considered as
rare forms of angioedema. The inherited
forms of the disease are better known
and, therefore, easier to recognize. Many
drug families are now found to be
responsible for the iatrogenic forms
(CEI’s, gliptins, estrogen
contraceptives… ). There are many new
developments in BK-mediated AE and
dermatologists are involved in advancing
clinical, nosological and therapeutic
knowledge.
Objectives:
This CME course will provide abundant
illustrations of skin manifestations (edema
of the face, genitals or abdominal wall,
occasional rash) and non-skin
manifestations (ENT or GI edema…). The
goal is to discuss bradykinin mediation in
angioedema and show how BK-mediated
AE is now classified based on mechanism
of onset. We will review the treatments
available for acute attacks (icatibant, C1inhibitor concentrate) or for long-term
prophylaxis (tranexamic acid,
progesterone…).
Learning outcomes:
- Recognize bradykinin mediation in AE.
- Differentiate between inherited and
iatrogenic BK-mediated AE.
▼ 11h00 – 12h30
FMC (CME) 63
Condyloma and intraepithelial neoplasia: Is a work-up necessary? If so, which one?
O. AYNAUD, D. KOTTLER, J. CHANAL
Moderator: N. DUPIN
This CME course provides an update on
whether or not condyloma patients
require a work-up. Another topic is what
to tell patients and their partners.
15
Objectives:
This CME course will address the pros
and cons of performing additional tests
such as anoscopy, or HPV detection
through molecular biology, in male or
female patients with anogenital condyloma
or intraepithelial neoplasia, as well as in
their partners.
Learning outcomes:
Performing and prescribing examinations
for patients with condyloma or
intraepithelial neoplasia.
Managing the patient’s partner.
Knowing what to say depending on the
circumstances.
English
09-13 December 2014
English
Friday, December 12
09-13 December 2014
Porte Maillot
Palais des Congrès
▼ 14h15 – 15h45
FMC (CME) 68
Pigmentation disorders
C. CHIAVERINI, J.Ph. LACOUR, T. PASSERON
There is more to pigmentation disorders
than just melasma or vitiligo. Dermatoses
that manifest through pigmentary
problems are fairly routine in daily
pediatric and adult practice. This raises
frequent diagnostic and/or therapeutic
issues.
Objectives:
The goal of this CME session is to discuss
hands-on, interactive clinical cases as
stepping stones for diagnosis and
treatment planning of pigmentary
dermatoses.
Learning outcomes:
Recognizing pigmentary disorders.
Suggesting optimum treatment for these
various forms of dermatosis.
▼ 14h15 – 15h45
FMC (CME) 69
Toxidermia: News on causality assessment, new alerts
B. LEVRUN-VIGNES, B. SASSOLAS, C. HADDAD - Moderator: B. MILPIED
On behalf of «RegiSCAR France»
The skin is where most adverse drug
reactions are manifested. Marketing new
agents requires constant alert updates,
allowing for primary or secondary
prevention strategies.
Dermatologists are on the front lines of
diagnosing toxidermia and detecting the
drug responsible. This makes them
instrumental in working with individual
patients and, on a collective scale, issuing
post-marketing drug safety alerts. In the
event of rare and/or severe toxidermia,
having an EU-level network (RegiSCAR) for
case detection and validation makes a key
contribution to disseminating information
on toxidermia.
16
Objectives:
1. Practical update on dermatological
expertise in two areas:
- Causality assessment based on clinical
cases,
- Organising alerts nationally and
internationally.
2. News on alerts.
Learning outcomes:
After this session, participants will be able
to identify the agent(s) suspected of
causing the toxidermia and decide
whether or not to continue the course of
treatment.
They will be able to initiate and help
organize the alert.
F
Friday, December 12
Porte Maillot
Palais des Congrès
▼ 16h15 – 17h45
FMC (CME) 79
Cutaneous adverse effects of targeted therapies in oncology
O. DEREURE, A. DU THANH, C. GIRARD
So-called « targeted » therapies currently
account for the bulk of cancer
treatments, particularly for skin cancer,
and are increasingly used as first-line
treatments. However, their use may be
restricted due to mucocutaneous adverse
effects being extremely common and
often highly specific. Therefore,
dermatologists are called upon regularly
to manage these adverse effects, which
can be extremely hard on patients, and
also to adjust the treatment causing
them.
Objectives:
Based on hands-on examples, this CME
course will review the most common
and/or troublesome mucocutaneous
adverse effects of various « targeted »
therapy classes currently used in
oncology, particularly against skin cancer.
The goal is to enable practitioners to
identify these adverse effects, assess
their severity and manage them, both
cutaneously and as part of a broader
therapeutic strategy.
Learning outcomes:
Knowing and recognizing the
mucocutaneous adverse effects of
« targeted » cancer therapies; provide
guidance to patients and to prescribing
oncologists, particularly based on 2014
guideline updates.
▼ 16h15 – 17h45
FMC (CME) 85
Lymphedema in children
L. MARTIN, X. DERIES, A. MARUANI
With the participation of F. VEAUX, physiotherapist
Dermatologists are all too familiar with
primary or secondary forms of voluminous
lymphedema (LE) that are refractory to all
treatment options in some adults. Yet,
this can remedied!
Early, intensive management reduces the
development of edema and related tissue
damage. It is, therefore, very important to
diagnose the disorder early in life.
Some genetically determined, primary
forms of LE start in childhood or
adolescence.
17
Objectives:
This CME course will look at the genetics
and physiopathology of pediatric LE, either
standalone or combined with other
disorders of the skin (yellow nail
syndrome), blood vessels (KlippelTrenaunay Syndrome) or GI tract. We will
review the early skin signs leading to LE
diagnosis and the necessary examinations
for achieving strict and suitable
management. Lastly, we will show how to
prescribe and monitor lymphatic
compression treatment, in order to
maintain LE reversibility over the years.
Learning outcomes:
- Recognize LE in children and look for
extra-cutaneous signs to determine
diagnosis and etiology.
- Prescribe and monitor physical
treatment of LE through lymphatic
drainage followed by compression bands
or stockings.
English
09-13 December 2014
English
Porte Maillot
www.jdp2014.com
09-13 December 2014
Palais des Congrès
What’s new ?
Grand amphithéâtre - Palais des Congrès de Paris (level 0.5)
▼ Saturday 13 December
What’s new in CLINICAL DERMATOLOGY ?
09h00 - 09h25
A. BARBAUD (Hôpitaux Brabois - Vandoeuvre-les-Nancy)
What’s new in INSTRuMENTAL DERMATOLOGY ?
09h25 - 09h40
J.M. AMICI (Cenon)
What’s new in INTERNAL MEDICINE ?
09h40 - 10h00
E. LAFFITTE (Hôpitaux Universitaires - Genève)
What’s new in PEDIATRIC DERMATOLOGY ?
10h55 - 11h10
P. PLANTIN (CH de Cornouaille - Quimper)
What’s new in CANCEROLOGY ?
11h10 - 11h30
T. JOUARY (CH - Pau)
What’s new in DERMATOLOGICAL TREATMENT ?
L. MEUNIER (CHRU Carémeau - Nimes)
18
11h30 - 12h00
English
General Information & Conditions
English
Porte Maillot
www.jdp2014.com
09-13 December 2014
Palais des Congrès
GENERAL INFORMATION & CONDITIONS
▼ Venue and dates
The JDP 2014 congress (scientific programme, posters, exhibition, FMC (CME) sessions, commercial exhibition) will take place from
09 to 13 December 2014 at the Palais des Congrès (Paris Convention Centre) 2, place de la Porte Maillot – 75017 Paris.
It is easily accessible by car (Parking Porte Maillot under the Convention Centre), by local city bus (lines: 82.73.43.244.PC), by
metro (line 1) or by RER (Paris Suburban Express Metropolitan Network, line C).
▼ Contact for JDP 2014 programme and exhibition
Sylvie FOJUTOWSKI - SFD
25, rue La Boétie - 75008 Paris - Tél. : (33).01.43.27.01.67 - Fax. : (33).01.43.27.01.86 - E.mail : [email protected]
▼ Contact for general organisation and logistics of JDP 2014
JDP 2014 - MCI
24, rue Chauchat - 75009 Paris – France
Tél. : (33).01.53.85.82.57 – Fax. : (33).01.53.85.82.83
E.mail : [email protected] or [email protected]
▼ On site welcome area
The congress secretariat (welcome area, registration desk) will be located on Level 3, Hall Havane (Neuilly side).
Opening hours :
- from Tuesday 09 December to Friday 12 December 2014 : 8:00 – 18:00
- on Saturday 13 December 2014 : 8:00 – 12:00 (level 0,5).
The congress documentation will be available there for pre-registered delegates and for anyone wishing to register on site.
Upon registration, an electronic badge confirmation will be sent to you containing a bar code. Do not forget to print this page and
bring it with you to the congress. You will have to scan the bar code and your badge will be printed automatically.
▼ Congress access
All participants must be registered. Admission to the scientific sessions and exhibition is by badge only.
A lost or a forgotten badge cannot be replaced.
▼ Lunches
Lunches/coffee breaks are NOT included in the registration fees.
▼ Important information
Acess to oral communications sessions, posters sessions, plenary sessions is included in the registration fees and does not require
pre-booking.
Sessions such as FMC (CME), workshops, forums must be pre-booked and some of them are subject to an additional fee (please
refer to programme).
For all sessions, you need to present your badge at conference room entrance for scan.
▼ Certificates of attendance
Certificates of attendance for pre-registered participants will be issued along with the Congress documentation upon arrival.
Participants who register on-site can request this certificate at the Welcome Desk (level 3).
▼ CME credits
CME certificates will be available to you after the event. It will be your responsibility to download your certificate at
www.sfdermato.com (JDP 2014 picture) and for processing with your national authority. Your access codes will be your family name
and your registration number.
20
09-13 December 2014
Palais des Congrès
▼ Insurance & Liability
The Congress Organisers (SFD and MCI) cannot be held liable for any hindrance or disruption of Congress proceedings arising from
political, social, health or economic events or any other unforeseen incidents beyond their control.
The congress cancellation conditions shall apply in any case. Registration of a participant entails acceptance of the cancellation
conditions.
The Congress Organisers strongly recommend that participants obtain adequate cover for cancellation travel, health, accident and
cancellation insurance before they depart from their countries.
The Congress Organisers will accept no liability for personal injuries sustained by or for loss or damage to property belonging to
congress participants either during or as a result of the Congress or during all events.
REGISTRATION
▼ How to register ?
Access to all congress activities is subject to registration.
Participants are encouraged to register in advance and as early as possible in order to benefit from lower registration fees, have
wider hotel accommodation choice and social events availability.
Registrations can be made on line only. All payment methods are accepted: check, bank transfer or credit card - VISA,
MASTERCARD, EUROCARD, AMERICAN EXPRESS.
Registration requests or changes by phone will not be processed.
Upon receipt of your registration and after payment clearance, the Congress Office will email you an electronic invoice summarizing
all registration and accommodation details and specifying payment status as well as Value Added Tax (VAT) amounts.
▼ Registration fees
Registration &
payment
uNTIL
07/11/2014
Registration &
payment
AFTER
07/11/2014
Members of the French Society of Dermatology (SFD)
200€
250€
120€
Practicing CCA, member of the SFD
100€
120€
80€
REGISTRATION category
(Fees quoted including French VAT)
Junior Members of the SFD
Free
1 DAY
PASS
Free
Member of one ADF Society
300€
340€
140€
Non member of the SFD, practicing CCA non member of the
SFD
400€
440€
180€
DES (resident), AFS, AFSA, Student (written proof of status
to be provided upon registration)
Free
Free
Nurse (individual payment)
30€
Not applicable
Nurse (registration supported by training programme)
50€
Not applicable
Non-medical researcher (written proof of status by the Director
of the Research Laboratory to be provided upon registration)
100€
120€
80€
Hospital pharmacist (written proof of status by the Director
of the Research Laboratory to be provided upon registration)
100€
120€
80€
Private Pharmacist
400€
440€
180€
Press (official and valid press card to be provided upon
registration)
21
Free
Free
English
Porte Maillot
www.jdp2014.com
English
Porte Maillot
www.jdp2014.com
09-13 December 2014
Palais des Congrès
▼ Sessions prices
SESSIONS (Fees quoted including French VAT)
Surgery workshops - 1A, 1B, 1C, 1D, 2A, 2B
150€
Other workshops : 3, 4, 5, 6, 7, 8, 9
100€
FMC (CME)*
25€
FMC 17
40€
New sessions "Latest News in Dermatology" (simultaneous interpretation)
25€
New session "ECHANGES FRANCOPHONES"
25€
New session "HOT TOPICS" (simultaneous interpretation)
free** but pre-booking
Forums
free** but pre-booking
Special session "Peau Noire"
free**
Plenary sessions (simultaneous interpretation)
free**
What's New on Saturday morning (simultaneous interpretation)
free**
* English simultaneous interpretation will be provided in the following sessions: FMC 1 - FMC 3 - FMC 10 - FMC 12 - FMC 18 FMC 21 - FMC 25 - FMC 28 - FMC 30 - FMC 34 - FMC 43 - FMC 46 - FMC 49 - FMC 54 - FMC 59 - FMC 63 - FMC 68 FMC 69 - FMC 79 - FMC 85
** We remind you that participation to workshops, FMC (CME), Forums and other sessions are subject to registration.
▼ VAT
Registration and sessions fees are subject to French VAT. VAT rate is of 20% (at date of printing – August 2014).
▼ On site registration
If you are pre-registered, do not forget to print the electronic badge confirmation containing a bar code you received and bring it
with you. Upon arrival at the congress center, go to the welcome desk “Electronic Badge” to scan your bar code and your badge will
be printed automatically.
If you do not have your electronic confirmation with you, staff will be there to help you.
If you wish to register on site, go to the desk “registration on site” (payment by card only) or to the welcome desk “new registration”.
We remind you that only registered participants can attend the scientific sessions.
▼ Name change
Name substitutions are not accepted and will be treated as new registrations with requested payment.
A processing fee of 30€ will be charged for changes in registration.
▼ Registration fees include:
-
Admission to the scientific sessions
Access to posters and exhibition areas
An electronic badge
Congress documents (Congress bag, final programme, abstracts)
Possibility to buy congress evening tickets.
22
www.jdp2014.com
Porte Maillot
Palais des Congrès
▼ Terms of payment
The Organising Committee has given mandate to MCI for the organisation of JDP 2014.
MCI is the sole competent company to receive payments for this Congress.
Payments may be made either:
• by credit card (Visa / Master Card / Eurocard / American Express)
• by cheque to the order of: JDP 2014 / MCI and sent to:
JDP 2014 – MCI France, 24 rue Chauchat - 75009 Paris – France
• by bank transfer to the order of JDP 2014/ MCI
Crédit Lyonnais / Paris La Fayette - Bank code : 30002 – Sort code : 05666
Account number 0000060223Z - KEY 25 -- IBAN : FR 33 3000 2056 6600 0006 0223 Z25 – BIC : CRLYFRPPXXX:
Do not forget to send a copy of your bank transfer when registering and to indicate the participant name on it.
▼ VAT
Registration fees are subject to French VAT. VAT rate is of 20% (August 2014).
▼ Cancellation policy
All cancellations must be notified in writing (by mail or e-mail) to the Congress Office according to the following conditions and
reimbursement will be processed AFTER the Congress.
• Registration
Requests for refunds made :
- Up to October 8, 2014: 50% will be reimbursed, except 80 € which will be withheld for administrative fee
- After October 8, 2014: no refund
• Accommodation
Requests for refunds made :
- Up to October 8 2014: deposit will be reimbursed, except reservation fees
- After October 8, 2014: no refund
For group conditions, please contact JDP 2014 Secretariat ([email protected]).
▼ Accommodation
Hotel rooms at special Congress rates are being held for participants in various hotels of different categories in the vicinity of the
Congress Venue.
A PREPAYMENT of the FULL STAY (including booking fees of 18 €) will be requested for all hotel reservations. It will be automatically
deducted from the total amount of your hotel bill when leaving.
CAT Hotels
Room type
Breakfast
City tax
4
HYATT REGENCY PARIS ETOILE
Queen room
230€
4
MERIDIEN ETOILE
Deluxe
220€
250€
included
included
250€
included
included
4
BEST WESTERN PREMIER REGENT'S GARDEN
Classic
229€
239€
included
included
4
WARWICK CHAMPS ELYSEES
Superior
230€
250€
included
included
4
AC PORTE MAILLOT
Standard
219€
229€
included
included
3
BEST WESTERN STAR CHAMPS-ELYSEES
Classic
178€
191€
included
included
3
CHARLEMAGNE
Standard
148€
167€
included
included
3
FERTEL ETOILE
Standard
154€
170€
included
included
3
FERTEL MAILLOT
Standard
154€
170€
included
included
3
MAGELLAN
Standard
175€
205€
included
included
3
RESIDENCE IMPERIALE
Superior
191€
207€
included
included
2
DES PAVILLONS
Standard
145€
145€
included
included
2
RESIDENCE VILLIERS
Standard
110,50€
119€
included
included
23
Single rate Double rate
English
09-13 December 2014
English
Porte Maillot
www.jdp2014.com
09-13 December 2014
Palais des Congrès
▼ Room rates
All rates are indicated in Euros, per night and per room. Reservations must be made through the Congress Office to guarantee the
indicated rates negotiated for the event.
Do not forget:
- If you shorten your stay, no refund will be made of the cancelled pre-paid room nights.
- In case of no-show, no refund will be issued.
- Bookings are ensured on a first-come first-served basis
Important :
Hotel requests received after October 8th 2014 will be confirmed accordingly to availability.
▼ Exhibition
An important scientific exhibition will take place during the JDP 2014, level 2 of the Palais des Congrès, Hall Maillot, from
Wednesday 10 to Friday 12 December 2014.
▼ Congress dinner
Friday 12 December 2014, the congress dinner will take place at the PRE-CATELAN.
Located in the heart of the Bois de Boulogne, the Pré-Catelan is a few minutes from the Porte Maillot.
In resplended settings dating back to the 1905 and rich in history and arts, you will appreciate a prestigious gastronomy and the
excellence of ingredients, thanks to the talent of Guy Krenzer (Executive Chef and Director of Creation) and Olivier Poussier (World’s
Best Sommelier 2000).
After an exquisite dinner cocktail, guests will enjoy dancing and listening live music performed by 17 musicians orchestra.
Return transfers from Porte Maillot will be organised.
Rates:
Congress participant: 70 €
Accompanying person: 90 €
24
Palais des Congrès
de Paris
Périphérique Nord
SE
IN
E
Hotels list :
1 - HYATT REGENCY PARIS ETOILE
7
2 - MERIDIEN ETOILE
Grande Arche
de la Défense
3 - BEST WESTERN PREMIER REGENT'S GARDEN
9
2
1
4 - WARWICK CHAMPS ELYSEES
Porte
Maillot
6
11
3
10
4
Place de
l'Etoile
Bois de
Boulogne
SE
IN
E
5 - AC PORTE MAILLOT
5
6 - BEST WESTERN STAR CHAMPS-ELYSEES
Palais de
Chaillot
Tour Eﬀeil
Périphérique Ouest
8 - FERTEL ETOILE
SE
INE
7 - CHARLEMAGNE
Basilique du
Sacré-Cœur
Place
Clichy
8
Rd Pt
des Champs
Elysées Place de
la Concorde
Place de
la République
Périphérique Est
Louvre
Musée d'Orsay
Invalides
SEIN
E
La
Conciergerie
Notre
Dame
Tour
Montparnasse
9 - FERTEL MAILLOT
Place de
la Bastille
Place de
la Nation
Panthéon
Bois de
Vincennes
Place
Denfert
Rochereau
11 - RESIDENCE IMPERIALE
Ile
St-Louis
E
IN
SE
10 - MAGELLAN
Centre
Pompidou
Place
d'Italie
12 - DES PAVILLONS
13 - RESIDENCE VILLIERS
Périphérique Sud
Level 1 – Palais des Congrès
NEUILLY
SIDE
PARIS
SIDE
GRAND
AMPHITHEATRE
Saturday 14 December
2014
AMPHI
BLEU
PARIS
SIDE
NEUILLY
SIDE
PARIS
SIDE
NEUILLY
SIDE
WELCOME
AND
POSTERS
AREA
Hall Maillot
Exhibition
Room
Maillot
Amphithéâtre
Havane
WELCOME
DESK
POSTERS
AREA
Amphi
Bordeaux
www.jdp2014.com
SCIENTIFIC & EXHIBITION
SECRETARIAT JDP 2014 :
Société Française de Dermatologie
S. Fojutowski
25, rue La Boétie - 75008 Paris
Tél. : (33).01.43.27.01.67 ou 56 - Fax. : (33).01.43.27.01.86
E-mail : [email protected]
REGISTRATION & ACCOMMODATION
SECRETARIAT:
MCI - JDP 2014
24, rue Chauchat - 75009 Paris - France
Tél. : (33).01.53.85.82.57
Fax. : (33).01.53.85.82.83
E-mail JDP 2014 : [email protected] - [email protected]
Web JDP 2014 : www.sfdermato.com

Mise en page 1

Transcription

Documents pareils

HOTELS TYPE OF ROOM SINGLE DOUBLE METRO LE MERIDIEN

Accommodation - IUT de Saint Denis

cv américain management

French Language Text / Theory and Practice 1st Year

ANNE BAQUET, soprano

Osmanisch – Türkische Literaturen Prof. Dr. Timour Muhidine (Paris

About us - Paris - Greystone residential

My Paris Concierge Focus

Jolie Môme / Sample repertoire

the 2016 brochure